亞振家居(603389.SH):預計半年度淨虧損2500萬元-3000萬元
格隆匯7月9日丨亞振家居(603389.SH)公佈,經財務部門初步測算,預計公司2024年半年度實現歸屬於母公司所有者的淨利潤-3,000萬元到-2,500萬元,預計公司2024年半年度實現歸屬於母公司所有者的扣除非經常性損益後的淨利潤為-3,100萬元到-2,600萬元。
1、受傢俱消費降級和消費習慣變化影響,高端傢俱客羣減少,公司實體門店客流量不足,經銷渠道拓展不及預期,渠道規模和質量未有較大改善,營業收入較上年同期略有下降;2、得益於公司降本增效相關措施,本期管理費用、銷售費用合計較上年同期減少約1,400萬元,但相較公司目前收入規模,管理費用率及銷售費用率仍然過高。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.